#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Indolent systemic mastocytosis Hypoparathyroidism Sickle cell anaemia Angiosarcoma metastatic Chondrosarcoma Cervix carcinoma Factor IX deficiency Anal fistula Cystic fibrosis lung Methylmalonic acidaemia Ewing's sarcoma recurrent Colorectal adenocarcinoma Chronic cutaneous lupus erythematosus Hypotransferrinaemia B-cell small lymphocytic lymphoma refractory More trials…

    Learn about Rare Diseases

    Bronchopulmonary dysplasia – Life with Disease Metachromatic leukodystrophy – Trials in Disease Bronchiolitis obliterans syndrome – Basic Information Myelodysplastic syndrome with excess blasts – Basic Information Antithrombin III deficiency – Treatment Myelodysplastic syndrome Mucopolysaccharidosis II SAPHO syndrome – Trials in Disease Alagille syndrome – Basic Information Richter’s syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Raludotatug Deruxtecan Sodium Iotalamate (125I) Deoxyribonucleic Acid Elebsiran Rocuronium Bromide Deferiprone Everolimus ALE.P03 Linaclotide Bexotegrast Fulvestrant Gad20-209-Fsp-A4 Ly3819469 Sodium Mps-103 Napabucasin Ropivacaine Hydrochloride Sar-443579 Citric Acid Monohydrate Mepolizumab Flortaucipir (18F) More therapies…

    Learn about Your Condition

    Macular oedema Myotonia IgA nephropathy Eye pain Familial hypertriglyceridaemia Neuromyopathy Breast cancer metastatic Cutaneous calcification Skin angiosarcoma Oral neoplasm Periarthritis Post-traumatic stress disorder Prostate cancer metastatic Demyelination Leukocyte adhesion deficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. ProLife Medica Sp. z O.O. ETG Poniatowa

ProLife Medica Sp. z O.O. ETG Poniatowa

Ul. Wladyslawa Kunickiego 26a, Poniatowa, 20-412, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

    Not recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    • Chronic kidney disease
    Investigated Drugs:
    • Ziltivekimab
    Belgium Bulgaria Croatia Czechia Denmark Germany +12

  • Study of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Apremilast
    • Zasocitinib
    Bulgaria Czechia France Germany Greece Hungary +3

  • Study of ISIS 678354 for Patients with Severe High Triglycerides

    Not recruiting

    3 1
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Belgium Bulgaria Czechia France Greece Hungary +9

  • Study on the Effectiveness and Safety of VRDN-003 for Patients with Chronic Thyroid Eye Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • VRDN-003
    Germany Hungary The Netherlands Poland Spain

  • Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren’s Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Efgartigimod Alfa
    Austria Belgium Bulgaria Estonia France Germany +12

  • Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Sonelokimab
    Bulgaria Croatia Czechia Estonia Finland France +10

  • Study on the Safety and Effects of ORG-129 in Patients with Fibrostenotic Crohn’s Disease

    Not recruiting

    2 1
    Investigated Drugs:
    • ORG-129
    Austria Denmark Germany Italy Poland Spain

  • Study on the Long-Term Safety of Relacorilant for Patients with Cushing Syndrome

    Not recruiting

    4 1 1
    Austria Bulgaria Germany Italy The Netherlands Poland +2

  • Study on Guselkumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Drugs:
    • Guselkumab
    Croatia Czechia France Germany Hungary Italy +4

  • Study on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Ruxolitinib
    Belgium Bulgaria France Germany Hungary Italy +3
Previous Page
1 2 3 4
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!